2024 Mid-Year Myeloma Review with Paul Richardson, MD, Dana Farber Cancer Institute

Learn about the latest in multiple myeloma advances with Paul Richardson, MD who will cover the recent American Society of Hematology and European Hematology Association meeting findings.